Revance Therapeutics, Inc. (RVNC)
USD 3.07
(0.0%)
USD 3.07
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 478.43 Million USD | 14.33% |
| 2022 | 418.46 Million USD | 28.95% |
| 2021 | 324.51 Million USD | 52.99% |
| 2020 | 212.1 Million USD | 622.93% |
| 2019 | 29.34 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 1.87 Million USD | -64.99% |
| 2016 | 5.34 Million USD | -36.95% |
| 2015 | 8.48 Million USD | 139.58% |
| 2014 | 3.54 Million USD | -86.12% |
| 2013 | 25.49 Million USD | -76.05% |
| 2012 | 106.44 Million USD | 54.3% |
| 2011 | 68.98 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 475.77 Million USD | -0.56% |
| 2024 Q2 | 491.63 Million USD | 3.33% |
| 2023 Q2 | 432.38 Million USD | -0.76% |
| 2023 Q1 | 435.71 Million USD | 4.12% |
| 2023 Q4 | 478.43 Million USD | -1.94% |
| 2023 FY | 478.43 Million USD | 14.33% |
| 2023 Q3 | 487.89 Million USD | 12.84% |
| 2022 Q1 | 492.47 Million USD | 51.76% |
| 2022 Q2 | 437.69 Million USD | -11.12% |
| 2022 FY | 418.46 Million USD | 28.95% |
| 2022 Q4 | 418.46 Million USD | -2.21% |
| 2022 Q3 | 427.9 Million USD | -2.24% |
| 2021 FY | 324.51 Million USD | 52.99% |
| 2021 Q4 | 324.51 Million USD | -0.34% |
| 2021 Q1 | 310.36 Million USD | 46.32% |
| 2021 Q3 | 325.61 Million USD | -0.4% |
| 2021 Q2 | 326.92 Million USD | 5.33% |
| 2020 Q2 | 201.96 Million USD | 1.07% |
| 2020 Q1 | 199.82 Million USD | 581.06% |
| 2020 FY | 212.1 Million USD | 622.93% |
| 2020 Q3 | 204.87 Million USD | 1.44% |
| 2020 Q4 | 212.1 Million USD | 3.53% |
| 2019 FY | 29.34 Million USD | 0.0% |
| 2019 Q4 | 29.34 Million USD | -2.51% |
| 2019 Q3 | 30.09 Million USD | -2.38% |
| 2019 Q1 | 31.52 Million USD | 0.0% |
| 2019 Q2 | 30.82 Million USD | -2.21% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | -100.0% |
| 2018 Q1 | 983 Thousand USD | -47.49% |
| 2017 Q1 | 4.48 Million USD | -16.12% |
| 2017 Q2 | 3.55 Million USD | -20.85% |
| 2017 Q3 | 2.72 Million USD | -23.18% |
| 2017 Q4 | 1.87 Million USD | -31.35% |
| 2017 FY | 1.87 Million USD | -64.99% |
| 2016 Q4 | 5.34 Million USD | -13.41% |
| 2016 Q2 | 6.97 Million USD | -9.93% |
| 2016 Q3 | 6.17 Million USD | -11.44% |
| 2016 Q1 | 7.74 Million USD | -8.71% |
| 2016 FY | 5.34 Million USD | -36.95% |
| 2015 Q4 | 8.48 Million USD | -7.76% |
| 2015 Q2 | 9.87 Million USD | 1087.38% |
| 2015 FY | 8.48 Million USD | 139.58% |
| 2015 Q1 | 832 Thousand USD | -76.5% |
| 2015 Q3 | 9.19 Million USD | -6.93% |
| 2014 Q3 | 9.7 Million USD | -17.42% |
| 2014 Q1 | 13.8 Million USD | -45.85% |
| 2014 FY | 3.54 Million USD | -86.12% |
| 2014 Q4 | 3.54 Million USD | -63.51% |
| 2014 Q2 | 11.74 Million USD | -14.9% |
| 2013 Q4 | 25.49 Million USD | 94.98% |
| 2013 Q3 | 13.07 Million USD | 0.0% |
| 2013 Q1 | 16.71 Million USD | -84.3% |
| 2013 FY | 25.49 Million USD | -76.05% |
| 2012 FY | 106.44 Million USD | 54.3% |
| 2012 Q4 | 106.44 Million USD | 0.0% |
| 2011 FY | 68.98 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -150350.943% |
| Better Therapeutics, Inc. | 14.88 Million USD | -3115.282% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17072.793% |
| Nutriband Inc. | 241.28 Thousand USD | -198185.845% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 72.501% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -3161.086% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1645.154% |
| BioAtla, Inc. | 2.46 Million USD | -19348.537% |
| Genelux Corporation | 2.51 Million USD | -18893.013% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -595500.538% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -235581.773% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1810.526% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2190.886% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -5527095.009% |
| Soligenix, Inc. | 3.49 Million USD | -13590.818% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kura Oncology, Inc. | 17.2 Million USD | -2681.593% |
| Dyadic International, Inc. | 136.92 Thousand USD | -349302.975% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -417.601% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -302706.329% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -22152.744% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -3323.744% |
| Autolus Therapeutics plc | 52.96 Million USD | -803.268% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -8670.559% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -8648.108% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -108.53% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3750.885% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1081.144% |
| INmune Bio, Inc. | 10.43 Million USD | -4484.018% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -166.347% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -223467.29% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7999.36% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -57762.668% |
| Opthea Limited | 200.62 Million USD | -138.467% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -720.909% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -726.711% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -8759.889% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -4107.123% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -7660.487% |
| NextCure, Inc. | 6.6 Million USD | -7143.512% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -76818.279% |
| Surrozen, Inc. | 3.37 Million USD | -14059.041% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -940.035% |
| Organovo Holdings, Inc. | 1.39 Million USD | -34220.947% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -255.702% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -465.605% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1483.38% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -670.735% |
| PureTech Health plc | 25.51 Million USD | -1775.329% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4775.512% |
| Mesoblast Limited | 118.92 Million USD | -302.306% |
| Turnstone Biologics Corp. | 3.21 Million USD | -14785.937% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3587.069% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -465.031% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -193597.976% |
| ChromaDex Corporation | 3.27 Million USD | -14499.756% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -151.882% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -359.229% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -331.301% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1155.6% |
| Seer, Inc. | 28.25 Million USD | -1593.032% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -7704.796% |
| Gritstone bio, Inc. | 104.77 Million USD | -356.63% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -978893.247% |
| Avid Bioservices, Inc. | 207.83 Million USD | -130.2% |
| Insmed Incorporated | 1.2 Billion USD | 60.263% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -362.094% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -49325.0% |
| MediWound Ltd. | 6.71 Million USD | -7029.101% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -371.903% |
| Fortress Biotech, Inc. | 88.59 Million USD | -440.042% |
| OmniAb, Inc. | 25.56 Million USD | -1771.734% |
| Alector, Inc. | 38.91 Million USD | -1129.339% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -123.634% |
| Zai Lab Limited | 15.15 Million USD | -3057.772% |
| Immunic, Inc. | 1.33 Million USD | -35764.618% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1407.734% |
| Veracyte, Inc. | 12.63 Million USD | -3688.076% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 25.809% |
| FibroGen, Inc. | 170.45 Million USD | -180.681% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5168.517% |
| ContextLogic Inc. | 6 Million USD | -7873.9% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -244.123% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -7194.313% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 91.746% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1292964.865% |
| ImmuCell Corporation | 11.96 Million USD | -3897.175% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 71.488% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -6438.663% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17072.793% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -961.465% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -957.64% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1008.281% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -892.005% |
| Vaxxinity, Inc. | 15.16 Million USD | -3054.233% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 43.628% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -46467.542% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -3370577.751% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 82.299% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -315.412% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -106083.931% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -6827.802% |
| Ardelyx, Inc. | 55.98 Million USD | -754.621% |
| Pluri Inc. | 29.61 Million USD | -1515.676% |
| Prothena Corporation plc | 11.83 Million USD | -3942.535% |
| Celularity Inc. | 65.41 Million USD | -631.36% |
| Rallybio Corporation | 392 Thousand USD | -121949.49% |
| Cue Biopharma, Inc. | 14.69 Million USD | -3155.76% |
| MeiraGTx Holdings plc | 89.26 Million USD | -435.976% |
| Omeros Corporation | 338.28 Million USD | -41.431% |
| Humacyte, Inc. | 58.1 Million USD | -723.381% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -25719.428% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -9710.006% |
| Blueprint Medicines Corporation | 774.12 Million USD | 38.197% |
| IO Biotech, Inc. | 2.49 Million USD | -19083.4% |
| Aptose Biosciences Inc. | 1 Million USD | -47278.803% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2301.657% |
| Century Therapeutics, Inc. | 48.17 Million USD | -893.199% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1043.403% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -9434.356% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1430.107% |
| Summit Therapeutics Inc. | 106.09 Million USD | -350.932% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -673.94% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -16558.565% |
| GRI Bio, Inc. | 14 Thousand USD | -3417285.714% |
| Pulmatrix, Inc. | 8.75 Million USD | -5364.07% |
| Cingulate Inc. | 3.13 Million USD | -15160.571% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -314.782% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1416.527% |
| Cytokinetics, Incorporated | 755.77 Million USD | 36.696% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -3474.671% |
| Acelyrin, Inc. | 1.19 Million USD | -39969.849% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -228793.886% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -8651.308% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -27286.033% |
| Vor Biopharma Inc. | 35.66 Million USD | -1241.655% |
| Roivant Sciences Ltd. | 499.74 Million USD | 4.265% |
| Evogene Ltd. | 1.13 Million USD | -41941.652% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1462.795% |
| ProKidney Corp. | 4.41 Million USD | -10741.468% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -38923.98% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -867178.166% |
| CorMedix Inc. | 667.63 Thousand USD | -71561.334% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -9111.282% |
| BioLineRx Ltd. | 11.59 Million USD | -4027.634% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1129.275% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2803.824% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -70779.111% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -22467.642% |
| MediciNova, Inc. | 215.92 Thousand USD | -221473.132% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -37839.998% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -156.709% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -15.278% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2152.62% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1170.201% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -294652.86% |
| Apollomics, Inc. | 4.66 Million USD | -10164.621% |
| 89bio, Inc. | 27.1 Million USD | -1664.918% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -13226.852% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -29162.018% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5122.508% |
| Ainos, Inc. | 5.96 Million USD | -7922.629% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3803.035% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3725.636% |
| Allakos Inc. | 41.46 Million USD | -1053.826% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -4321.347% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -316743.709% |
| NLS Pharmaceutics AG | 1.63 Million USD | -29184.479% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -423292.92% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -402.974% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -8526.65% |
| Precigen, Inc. | 7.09 Million USD | -6641.356% |
| XOMA Corporation | 124.45 Million USD | -284.439% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2426.985% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -390.164% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -19075.711% |
| Incyte Corporation | 38.28 Million USD | -1149.599% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -158999.344% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1008.333% |
| MiMedx Group, Inc. | 48.09 Million USD | -894.686% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -4195.511% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -585641.92% |
| CRISPR Therapeutics AG | 238.63 Million USD | -100.49% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1737.093% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -136987.106% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -146437.292% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1704.526% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -291686.762% |
| UroGen Pharma Ltd. | 100.21 Million USD | -377.412% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -161.798% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -138039.18% |
| Entera Bio Ltd. | 390 Thousand USD | -122575.385% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -388.727% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -108.749% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -156763.607% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6899.766% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -70.483% |
| Chimerix, Inc. | 2.14 Million USD | -22215.019% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -49071.017% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1245.607% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -276975.165% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1772.1% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -121948.867% |
| Histogen Inc. | 4.62 Million USD | -10251.233% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -291686.762% |
| Portage Biotech Inc. | 47 Thousand USD | -1017844.681% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -37839.998% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -657.411% |
| OncoCyte Corporation | 2.86 Million USD | -16575.985% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -36724.824% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2240808.665% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -317682.324% |
| Purple Biotech Ltd. | 351 Thousand USD | -136205.983% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1905.877% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -11191.81% |
| Amarin Corporation plc | 8.73 Million USD | -5375.953% |
| TG Therapeutics, Inc. | 110.79 Million USD | -331.819% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -8764.814% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -9046.129% |
| NLS Pharmaceutics AG | 1.63 Million USD | -29184.479% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -33616.279% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1689.341% |
| Curis, Inc. | 2.79 Million USD | -17023.622% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -4267.266% |
| Daré Bioscience, Inc. | 5.31 Million USD | -8896.257% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -22293.888% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -84578.584% |
| Bicycle Therapeutics plc | 44.95 Million USD | -964.227% |
| BeiGene, Ltd. | 930.18 Million USD | 48.566% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2978.231% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -41831.113% |
| Erasca, Inc. | 55.85 Million USD | -756.503% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2346.357% |
| bluebird bio, Inc. | 330.32 Million USD | -44.837% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 57.805% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -234528.833% |
| Fortress Biotech, Inc. | 88.59 Million USD | -440.042% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4756.212% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Galecto, Inc. | 249 Thousand USD | -192042.169% |
| XBiotech Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1679.822% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1795.914% |
| Molecular Templates, Inc. | 12.23 Million USD | -3811.971% |
| NexImmune, Inc. | 68.8 Thousand USD | -695207.3% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 0.501% |
| Verastem, Inc. | 41.55 Million USD | -1051.272% |
| Imunon, Inc. | 1.62 Million USD | -29347.275% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -18721.164% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2437.708% |
| Onconetix, Inc. | 9.88 Million USD | -4739.622% |
| MacroGenics, Inc. | 33.97 Million USD | -1308.36% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -18.195% |
| GT Biopharma, Inc. | 58 Thousand USD | -824786.207% |
| Adagene Inc. | 22.3 Million USD | -2044.783% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -333.529% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -127.673% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -359.608% |
| Annexon, Inc. | 31.35 Million USD | -1425.862% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2257.631% |
| SciSparc Ltd. | 76 Thousand USD | -629418.421% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -6816.785% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -3354.397% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -483.336% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -145320.669% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1791.193% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -132.344% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -794.838% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -13577387.492% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 82.165% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -6147.998% |
| Immunocore Holdings plc | 84.03 Million USD | -469.347% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -759319.048% |
| 2seventy bio, Inc. | 256.67 Million USD | -86.398% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -566.278% |
| ADMA Biologics, Inc. | 141.41 Million USD | -238.312% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -19419.983% |
| Clene Inc. | 32.16 Million USD | -1387.622% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -945.232% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -735952.308% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4546.795% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -8424.962% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -21696.538% |
| Mereo BioPharma Group plc | 5.95 Million USD | -7938.206% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -99315.89% |
| Absci Corporation | 15.95 Million USD | -2898.27% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -28617.527% |
| aTyr Pharma, Inc. | 15.09 Million USD | -3069.487% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2682.078% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -29220.75% |
| Trevena, Inc. | 35.23 Million USD | -1257.914% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 68.088% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1640.709% |
| Orgenesis Inc. | 22.62 Million USD | -2014.999% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -10280.43% |
| GH Research PLC | 343 Thousand USD | -139385.131% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -7265.055% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1166812.195% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1672.634% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -95414.301% |
| Jaguar Health, Inc. | 35.86 Million USD | -1234.172% |
| Clearside Biomedical, Inc. | 43 Million USD | -1012.611% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -79242.289% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -736.35% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -102789.032% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Xencor, Inc. | 83.43 Million USD | -473.428% |
| Replimune Group, Inc. | 75.86 Million USD | -530.605% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -38980.529% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4987.558% |
| Kronos Bio, Inc. | 28.27 Million USD | -1592.254% |
| Innoviva, Inc. | 449.07 Million USD | -6.537% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2266.259% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -601.208% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -30667.46% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -19694.539% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -37870.952% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -15045.109% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1088.095% |
| HilleVax, Inc. | 51.19 Million USD | -834.569% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2842.193% |
| ImmunityBio, Inc. | 883.67 Million USD | 45.859% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Korro Bio, Inc. | 33.2 Million USD | -1340.762% |
| Genprex, Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -1644.263% |
| Kineta, Inc. | 1.31 Million USD | -36227.563% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -13350.492% |
| Aptorum Group Limited | 3.36 Million USD | -14128.956% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Codexis, Inc. | 22.36 Million USD | -2039.304% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -3212.337% |
| Celularity Inc. | 65.41 Million USD | -631.36% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -824.903% |
| Agenus Inc. | 350.24 Million USD | -36.599% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2759.566% |
| Cibus, Inc. | 24.62 Million USD | -1843.195% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -574.079% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -124817.493% |
| Kodiak Sciences Inc. | 181.63 Million USD | -163.408% |
| DBV Technologies S.A. | 14.38 Million USD | -3226.848% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -537.606% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -20328.437% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -12158.109% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 67.085% |
| Peak Bio, Inc. | 10.72 Million USD | -4362.252% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -19022.062% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -2870.208% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -7606.733% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -28260.047% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -329.127% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -10202.196% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -939.193% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1389.613% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -48471.98% |
| Alkermes plc | 290.73 Million USD | -64.563% |
| Arcellx, Inc. | 97.62 Million USD | -390.073% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -22163.099% |
| Adicet Bio, Inc. | 20.92 Million USD | -2186.532% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -15323.404% |
| Moolec Science SA | 2.64 Million USD | -17986.266% |
| Prime Medicine, Inc. | 13.63 Million USD | -3409.382% |
| Aditxt, Inc. | 18.21 Million USD | -2526.163% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -456.973% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -7478.552% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -951.272% |
| Royalty Pharma plc | 6.13 Billion USD | 92.202% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -3026.407% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -19818.152% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -59082.684% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -415012.708% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1314.23% |
| Humacyte, Inc. | 58.1 Million USD | -723.381% |
| Structure Therapeutics Inc. | 5.45 Million USD | -8673.774% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -35657.399% |
| Notable Labs, Ltd. | 2.04 Million USD | -23249.634% |
| Liquidia Corporation | 3.5 Million USD | -13557.836% |
| Mustang Bio, Inc. | 2.49 Million USD | -19052.682% |
| Immunovant, Inc. | 138 Thousand USD | -346591.304% |
| Vericel Corporation | 88.14 Million USD | -442.793% |
| Invivyd, Inc. | 2.16 Million USD | -21998.568% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -5385.999% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -119508.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -790.806% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -1537.127% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -689.769% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2215.638% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -118618.114% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -844.178% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -147.647% |
| PepGen Inc. | 20.1 Million USD | -2279.795% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -83250.871% |
| United Therapeutics Corporation | 700 Million USD | 31.652% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1488.11% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -473597.03% |
| Belite Bio, Inc | 886 Thousand USD | -53899.323% |
| Pharming Group N.V. | 171.54 Million USD | -178.897% |
| XOMA Corporation | 124.45 Million USD | -284.439% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -8531.319% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -99.665% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -23421.84% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2142.905% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| AbCellera Biologics Inc. | 77.38 Million USD | -518.292% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -473.738% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2742.745% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -14059.041% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1849.45% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -46259.884% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -284.161% |
| Evaxion Biotech A/S | 10.86 Million USD | -4301.547% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5168.517% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -538.704% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -7.499% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -165080.584% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3503.751% |
| BioVie Inc. | 6.11 Million USD | -7728.49% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -52707.285% |
| Compugen Ltd. | 1.35 Million USD | -35313.323% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -213200.936% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -203948.262% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2173.062% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -2360.447% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1018.725% |
| Benitec Biopharma Inc. | 284 Thousand USD | -168362.676% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -465.826% |
| Celcuity Inc. | 37.44 Million USD | -1177.654% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -308.245% |
| PolyPid Ltd. | 11.77 Million USD | -3961.754% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1579.482% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -423.119% |
| IN8bio, Inc. | 4.89 Million USD | -9677.928% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -351.08% |
| Instil Bio, Inc. | 86.05 Million USD | -455.97% |
| Quantum-Si incorporated | 15.3 Million USD | -3026.407% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -585641.92% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -4288.095% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -28843.376% |
| Solid Biosciences Inc. | 26.26 Million USD | -1721.565% |
| Immuneering Corporation | 4.46 Million USD | -10620.107% |
| Verona Pharma plc | 51.32 Million USD | -832.093% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3503.751% |
| uniQure N.V. | 138.4 Million USD | -245.667% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -4075.91% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -460.076% |
| Shattuck Labs, Inc. | 4.2 Million USD | -11285.864% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3501.039% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -11343.052% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -81683.59% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -227196.438% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -174510.949% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -100622.947% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1487.53% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -48471.98% |
| Immunome, Inc. | 1.65 Million USD | -28896.0% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -27507.271% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4792.964% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -132064.088% |
| Altimmune, Inc. | 671 Thousand USD | -71201.639% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -824.064% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -6711.418% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1483.734% |
| Moolec Science SA | 2.64 Million USD | -17986.266% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6.58 Million USD | -7165.513% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4792.964% |
| 180 Life Sciences Corp. | 1.32 Million USD | -36143.105% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2301.657% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2701.116% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -30667.46% |
| Nutriband Inc. | 241.28 Thousand USD | -198185.845% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -57821.792% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -2292.17% |
| Neurogene Inc. | 16.25 Million USD | -2843.304% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -115185.301% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -55.264% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 224.26 Thousand USD | -213238.982% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1576.304% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 21.692% |
| AnaptysBio, Inc. | 17.81 Million USD | -2585.719% |
| Design Therapeutics, Inc. | 3.05 Million USD | -15586.361% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -182508.397% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -3262.623% |
| Achilles Therapeutics plc | 4.61 Million USD | -10266.934% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -336825.352% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4584.559% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -28.019% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1489.535% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -12838.111% |
| Palisade Bio, Inc. | 369 Thousand USD | -129556.911% |
| Beam Therapeutics Inc. | 173.17 Million USD | -176.275% |
| AEON Biopharma, Inc. | 278 Thousand USD | -171998.561% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -142716.119% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -447490.536% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -530.664% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -682.945% |
| Athira Pharma, Inc. | 1.58 Million USD | -30085.11% |
| Vaccinex, Inc. | 247 Thousand USD | -193597.976% |
| HCW Biologics Inc. | 6.45 Million USD | -7315.538% |
| XOMA Corporation | 124.45 Million USD | -284.439% |
| Nektar Therapeutics | 230.4 Million USD | -107.653% |
| Arvinas, Inc. | 3.4 Million USD | -13971.588% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -29220.75% |
| Merus N.V. | 12.16 Million USD | -3833.843% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -272.531% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -3363.399% |
| Rezolute, Inc. | 2.22 Million USD | -21373.698% |
| Clene Inc. | 32.16 Million USD | -1387.622% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -273208.084% |
| BeyondSpring Inc. | 3.99 Million USD | -11875.82% |
| Synlogic, Inc. | 17.27 Million USD | -2669.517% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -36702.615% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1366854.286% |
| Peak Bio, Inc. | 10.72 Million USD | -4362.252% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -821.43% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5810.972% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -170.277% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -6679.566% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -350159.894% |
| MannKind Corporation | 382.37 Million USD | -25.12% |
| Ikena Oncology, Inc. | 10.73 Million USD | -4355.522% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -116876.528% |
| Gossamer Bio, Inc. | 212.46 Million USD | -125.184% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -274862.069% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5122.508% |
| Legend Biotech Corporation | 328.67 Million USD | -45.566% |
| Mural Oncology plc | 15 Million USD | -3087.647% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -908.801% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -22671.728% |
| Champions Oncology, Inc. | 7.43 Million USD | -6339.219% |
| REGENXBIO Inc. | 89.29 Million USD | -435.82% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -55877.03% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -86418.91% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -8736.978% |
| Vaxart, Inc. | 26.51 Million USD | -1704.458% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2955.649% |
| Cellectis S.A. | 92.85 Million USD | -415.26% |
| Longeveron Inc. | 2.04 Million USD | -23341.156% |
| Repare Therapeutics Inc. | 3.41 Million USD | -13930.323% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 65.748% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -926.859% |
| Revolution Medicines, Inc. | 87.94 Million USD | -444.021% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -276451.445% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -12003.061% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -150825.552% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -273290.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 40.817% |
| Denali Therapeutics Inc. | 52.24 Million USD | -815.821% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -3221.198% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -34720.524% |
| Cingulate Inc. | 3.13 Million USD | -15160.571% |
| Passage Bio, Inc. | 26.29 Million USD | -1719.556% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -7078.305% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -117163.235% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -53416.107% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -444.021% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2226.9% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -37870.952% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -19418.987% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -15219.693% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -58893.095% |
| OmniAb, Inc. | 25.56 Million USD | -1771.734% |
| Anew Medical, Inc. | 1.6 Million USD | -29708.972% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1517.267% |
| Lipocine Inc. | 17.16 Thousand USD | -2787002.412% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -4010.964% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1281.639% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7999.36% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -736.818% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -235581.773% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -9163.001% |
| Ocugen, Inc. | 6.94 Million USD | -6792.868% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3286.184% |
| Q32 Bio Inc. | 1.31 Million USD | -36200.0% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -71095.536% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1368.49% |
| Equillium, Inc. | 824 Thousand USD | -57962.379% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -5169.677% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -158950.684% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -214.141% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -835.574% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -61629.596% |
| Dominari Holdings Inc. | 3.02 Million USD | -15700.33% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -506249.022% |
| vTv Therapeutics Inc. | 529 Thousand USD | -90341.21% |
| Bio-Techne Corporation | 419.53 Million USD | -14.038% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -564.529% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -147.168% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2732.982% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2001.898% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -7797.557% |
| Nkarta, Inc. | 88.33 Million USD | -441.589% |
| BioCardia, Inc. | 1.31 Million USD | -36282.814% |
| Iterum Therapeutics plc | 19.5 Million USD | -2352.376% |